 Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Descriptor ID |
D002312
|
| MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
| Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
Idiopathic Hypertrophic Subaortic Stenosis- Idiopathic Hypertrophic Subaortic Stenosis
- IHSS
- IHSSs
- Subvalvular Stenosis, Idiopathic Hypertrophic
- Hypertrophic Cardiomyopathy, Idiopathic
- Cardiomyopathies, Idiopathic Hypertrophic
- Cardiomyopathy, Idiopathic Hypertrophic
- Hypertrophic Cardiomyopathies, Idiopathic
- Idiopathic Hypertrophic Cardiomyopathies
- Idiopathic Hypertrophic Cardiomyopathy
- Hypertrophic Obstructive Cardiomyopathy (HOCM)
- Cardiomyopathies, Hypertrophic Obstructive (HOCM)
- Cardiomyopathy, Hypertrophic Obstructive (HOCM)
- Hypertrophic Obstructive Cardiomyopathies (HOCM)
- Idiopathic Hypertrophic Subvalvular Stenosis
- Idiopathic Hypertrophic Subaortic Stenosis (IHSS)
Asymmetric Septal Hypertrophy- Asymmetric Septal Hypertrophy
- Asymmetric Septal Hypertrophies
- Hypertrophies, Asymmetric Septal
- Hypertrophy, Asymmetric Septal
- Septal Hypertrophies, Asymmetric
- Septal Hypertrophy, Asymmetric
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1986 | 1 | 0 | 1 | | 1995 | 1 | 1 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.
-
Masrur S, Memon S, Chhabra L, Parker MW, Duvall L. SPECT Myocardial Perfusion Imaging in the Diagnosis of Apical Hypertrophic Cardiomyopathy. Tex Heart Inst J. 2016 Oct; 43(5):467-468.
-
Mun JY, Kensler RW, Harris SP, Craig R. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol. 2016 Feb; 91:141-7.
-
Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circ Heart Fail. 2014 Nov; 7(6):967-75.
-
Vassileva CM, Boley T, Markwell S, Hazelrigg S. Mitral valve repair is underused in patients with hypertrophic obstructive cardiomyopathy. Heart Surg Forum. 2011 Dec; 14(6):E376-9.
-
Josephson L. Hypertrophies and intraventricular conduction defects: causes, presentation, and significance. Dimens Crit Care Nurs. 2010 Nov-Dec; 29(6):259-75.
-
Aslam F, Haque A, Foody J, Shirani J. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):240-5.
-
Debold EP, Saber W, Cheema Y, Bookwalter CS, Trybus KM, Warshaw DM, Vanburen P. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol. 2010 Feb; 48(2):286-92.
-
Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C, Greytak S, Woulfe K, Trivedi CM, Woodgett JR, Epstein JA, Force T, Huggins GS. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest. 2008 Nov; 118(11):3609-18.
-
Debold EP, Schmitt JP, Patlak JB, Beck SE, Moore JR, Seidman JG, Seidman C, Warshaw DM. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am J Physiol Heart Circ Physiol. 2007 Jul; 293(1):H284-91.
-
Panou FK, Kotseroglou VK, Lakoumentas JA, Chrysanthopoulou SA, Armeniakos JA, Stratigou T, Veve H, Zacharoulis AA. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Hellenic J Cardiol. 2006 Nov-Dec; 47(6):344-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|